The Inducement Grant was granted pursuant to Aligos' 2024 Inducement Plan (the "Plan”) as an inducement material to this ...

Aligos Therapeutics (ALGS) announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Arvinas (ARVN), 924% surge in interest Janux Therapeutics ...

Athabasca Oil Corporation (TSX: ATH) ("Athabasca” or the "Company”) is pleased to announce that the Toronto Stock Exchange ("TSX”) has approved the renewal of the Corporation's normal course issuer ...